Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
6,63 USD | +1,07% |
|
+20,77% | +48,65% |
20/06 | Aandelen Ocular Therapeutix stijgen nadat TD Cowen de rating heeft opgewaardeerd en het koersdoel heeft verhoogd | MT |
20/06 | OCULAR THERAPEUTIX, INC. : TD Cowen zet aandeel op kooplijst | ZM |
Vakgebied
Aantal werknemers: 267
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Bioresorbable Hydrogel Platform Technology
99,0
%
| 50 | 98,0 % | 58 | 99,0 % | +14,69% |
Collaboration
1,0
%
| 1 | 2,0 % | 1 | 1,0 % | -44,74% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 51 | 100,0 % | 58 | 100,0 % | +13,49% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Donald Notman
DFI | Director of Finance/CFO | 64 | 25-09-17 |
Chief Tech/Sci/R&D Officer | - | 28-09-21 | |
Jeffrey S. Heier
CTO | Chief Tech/Sci/R&D Officer | 63 | 11-09-15 |
Peter Jarrett
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-07 |
Scott Corning
IRO | Public Communications Contact | - | 01-01-10 |
Tracy Smith
HRO | Human Resources Officer | - | 01-09-20 |
Peter K. Kaiser
PRN | Corporate Officer/Principal | - | 22/02 |
General Counsel | 64 | 25-08-20 | |
Corporate Officer/Principal | 62 | 11-07-19 | |
Pauline Jen Ryan
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Adrienne Graves
BRD | Director/Board Member | 69 | 10-07-23 |
Director/Board Member | 76 | 05-11-12 | |
Merilee Raines
BRD | Director/Board Member | 68 | 20-09-21 |
Charles Warden
BRD | Director/Board Member | 55 | 01-01-08 |
Leslie Williams
BRD | Director/Board Member | 64 | 20-03-19 |
Jeffrey S. Heier
CTO | Chief Tech/Sci/R&D Officer | 63 | 11-09-15 |
Pravin Dugel
CEO | Chief Executive Officer | 60 | 21/02 |
Seung Suh Hong
BRD | Director/Board Member | 66 | 11-06-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 154 888 915 | 153 675 002 ( 99,22 %) | 0 | 99,22 % |
Bedrijfsgegevens
![Adres Ocular Therapeutix, Inc.(OCUL)](https://cdn.zonebourse.com/static/address/16917490.png)
Sector
Verkoop per activiteit
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+48,65% | 1,03 mld. | |
+54,61% | 811 mld. | |
+44,25% | 640 mld. | |
-6,33% | 353 mld. | |
+20,62% | 333 mld. | |
+10,44% | 302 mld. | |
+18,45% | 246 mld. | |
+2,09% | 225 mld. | |
+13,03% | 218 mld. | |
+8,61% | 168 mld. |
- Beurs
- Aandelen
- Koers OCUL
- Onderneming Ocular Therapeutix, Inc.